Indole-3-carbinol protects against cisplatin-induced acute nephrotoxicity: Role of calcitonin gene-related peptide and insulin-like growth factor-1

Scientific Reports

Volumn 6, Issue , 2016, Pages

  El Naga, Reem N ^a   Mahran, Yasmen F ^a  

^a Ain Shams University   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CALCITONIN GENE RELATED PEPTIDE; CISPLATIN; GLUTATHIONE; INDOLE DERIVATIVE; INDOLE-3-CARBINOL; SOMATOMEDIN C;

ACUTE KIDNEY FAILURE; ANIMAL; APOPTOSIS; CHEMICALLY INDUCED; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIPID PEROXIDATION; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RAT;

ACUTE KIDNEY INJURY; ANIMALS; ANTIOXIDANTS; APOPTOSIS; CALCITONIN GENE-RELATED PEPTIDE; CISPLATIN; GENE EXPRESSION REGULATION; GLUTATHIONE; HUMANS; INDOLES; INSULIN-LIKE GROWTH FACTOR I; LIPID PEROXIDATION; OXIDATIVE STRESS; RATS;

EID: 84978776057     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29857     Document Type: Article

References (60)

1. Rosenberg, B. Platinum complexes for the treatment of cancer: why the search goes on. In: Cisplatin. Chemistry and biochemistry of a leading anticancer drug (Lippert, B., ed.). Wiley-VCH, Basel, Switzerland, pp, 3-27 (1999).
2. Santos, N. A. et al. Cisplatin-induced nephrotoxicity is associated with oxidative stress, redox state unbalance, impairment of energetic metabolism and apoptosis in rat kidney mitochondria. Arch. Toxicol. 81, 495-504 (2007).
3. Miller, R. P., Tadagavadi, R. K., Ramesh, G., Reeves, W. B. Mechanisms of Cisplatin nephrotoxicity. Toxins (Basel) 2, 2490-2518 (2012).
4. Arany, I., Safirstein, R. L. Cisplatin nephrotoxicity. Semin. Nephrol. 23, 460-464 (2003).
5. Taguchi, T., Nazneen, A., Abid, M. R., Razzaque, M. S. Cisplatin-associated nephrotoxicity and pathological events. Contrib. Nephrol. 148, 107-121 (2005).
6. Santoso, J. T., Lucci, J. A., Coleman, R. L., Schafer, I., Hannigan, E. V. Saline, mannitol, and furosemide hydration in acute cisplatin nephrotoxicity: A randomized trial. Cancer Chemother. Pharmacol. 52, 13-18 (2003).
7. McGuinness, S. J., Ryan, M. P. Mechanism of cisplatin nephrotoxicity in rat renal proximal tubule suspensions. Toxicol. in vitro 8, 1203-1212 (1994).
8. Endo, T., Kimura, O., Sakata, M. Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line. Toxicol. 146, 187-195 (2000).
9. Safirstein, R., Miller, P., Guttenplan, J. B. Uptake and metabolism of cisplatin by rat kidney. Kidney Int. 25, 753-758 (1984).
10. Olivero, O. A., Chang, P. K., LopezLarraza, D. M., SeminoMora, M. C., Poirier, M. C. Preferential formation and decreased removal of cisplatin-DNA adducts in Chinese hamster ovary cell mitochondrial DNA as compared to nuclear DNA. Mutat. Res. Genet. Toxicol. Environ. Mutagen. 391, 79-86 (1997).
11. Kim, J. H. et al. Human adipose tissue-derived mesenchymal stem cells protect kidneys from cisplatin nephrotoxicity in rats. Am. J. Physiol. Renal Physiol. 302, F1141-F1150 (2012).
12. Sahu, B. D., Kuncha, M., Putcha, U. K., Sistla, R. Effect of metformin against cisplatin induced acute renal injury in rats: A biochemical and histoarchitectural evaluation. Exp. Toxicol. Pathol. 65, 933-940 (2013).
13. Guerrero-Beltrán, C. E. et al. Sulforaphane, a natural constituent of broccoli, prevents cell death and inflammation in nephropathy. J. Nutr. Biochem. 23, 494-500 (2012).
14. Zhang, B., Ramesh, G., Norbury, C., Reeves, W. B. Cisplatin-induced nephrotoxicity is mediated by tumor necrosis factor-produced by renal parenchymal cells. Kidney Int. 72, 37-44 (2007).
15. Aggarwal, B. B., Ichikawam H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4, 1201-1215 (2005).
16. Trusov, N. V. et al. Effects of combined treatment with resveratrol and indole-3-carbinol. Bull. Exp. Biol. Med. 149, 213-218 (2010).
17. El-Shinnawy, N. A., Abd-Elmageid, S. A., Alshailabi, E. M. Evaluation of antiulcer activity of indole-3-carbinol and/or omeprazole on aspirin-induced gastric ulcer in rats. Toxicol. Ind. Health 30, 357-375 (2014).
18. Ping, J. et al. Indole-3-carbinol enhances the resolution of rat liver fibrosis and stimulates hepatic stellate cell apoptosis by blocking the inhibitor of B kinase/inhibitor of B-/nuclear factor-B pathway. J. Pharmacol. Exp. Ther. 339, 694-703 (2011).
19. Jiang, J. et al. Indole-3-carbinol inhibits LPS-induced inflammatory response by blocking TRIF-dependent signaling pathway in macrophages. Food Chem. Toxicol. 57, 256-261 (2013).
20. Choi, Y., Kim, Y., Park, S., Lee, K. W., Park, T. Indole-3-carbinol prevents diet-induced obesity through modulation of multiple genes related to adipogenesis, thermogenesis or inflammation in the visceral adipose tissue of mice. J. Nutr. Biochem. 23, 1732-1739 (2012).
21. El-Naga, R. N., Ahmed, H. H., Abd Al Haleem, E. N. Effects of indole-3-carbinol on clonidine-induced neurotoxicity in rats: Impact on oxidative stress, inflammation, apoptosis and monoamine levels. Neurotoxicology. 44, 48-57 (2014).
22. Rostoka, E. et al. Effects of lycopene, indole-3-carbinol, and luteolin on nitric oxide production and iNOS expression are organspecific in rats. Arh. Hig. Rada. Toksikol. 61, 275-285 (2010).
23. Aggarwal, B. B., Shishodia, S. Molecular targets of dietary agents for prevention and therapy of cancer. Biochem. Pharmacol. 71, 1397-1421 (2006).
24. Benninghoff, A. D., Williams, D. E. The role of estrogen receptor in transplacental cancer prevention by indole-3-carbinol. Cancer Prev. Res. (Phila.) 26, 339-348 (2012).
25. Brandi, G. et al. Antitumoral activity of indole-3-carbinol cyclic tri-and tetrameric derivatives mixture inhuman breast cancer cells: in vitro and in vivo studies. Anticancer Agents Med. Chem. 13, 654-662 (2013).
26. Abou El Naga, R. N. et al. Sensitization of TRAIL-induced apoptosis in human hepatocellular carcinoma HepG2 cells by phytochemicals. Life Sci. 92, 555-561 (2013).
27. Saleh, S., El-Demerdash, E. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide. Basic Clin. Pharmacol. Toxicol. 97, 91-97 (2005).
28. Arjumand, W., Sultana, S. Glycyrrhizic acid. a phytochemical with a protective role against cisplatin-induced genotoxicity and nephrotoxicity. Life Sci. 89, 422-429 (2011).
29. El-Naga, R. N. Pre-treatment with cardamonin protects against cisplatin-induced nephrotoxicity in rats: Impact on NOX-1, inflammation and apoptosis. Toxicol. Appl. Pharmacol. 274, 87-95 (2014).
30. Máthé, C. et al. Protective effect of CV247 against cisplatin nephrotoxicity in rats. Hum. Exp. Toxicol. 33, 789-799 (2013).
31. Bradford, M. M. Rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254 (1976).
32. Ellman, G. L. Tissue sulfhydryl groups. Arch. Biochem. Biophy. 82, 70-77 (1959).
33. Mihara, M., Uchiyama, M. Determination of malondialdehyde precursor in tissues by thiobarbituric acid test. Anal. Biochem. 86, 271-278 (1978).
34. Banchroft, J. D., Stevens, A., Turner, D. R. Theory and practice of histological techniques Fourth Ed. Churchil Livingstone, New York, London, San Francisco, Tokyo, 1996.
35. Skehan, P. et al. New colorimetric cytotoxicity assay for anticancer drug screening. J. Natl. Cancer. Inst. 82, 1107-1112 (1990).
36. Oršoli, N. et al. Synergism between propolis and hyperthermal intraperitoneal chemotherapy with cisplatin on ehrlich ascites tumor in mice. J. Pharm. Sci. 102, 4395-4405 (2013).
37. Ghosh, P. et al. Sensitization of cisplatin therapy by a naphthalimide based organoselenium compound through modulation of antioxidant enzymes and p53 mediated apoptosis. Free Radic. Res. 49, 453-471 (2015).
38. Pan, H. et al. Cannabidiol attenuates cisplatin-induced nephrotoxicity by decreasing oxidative/nitrosative stress, inflammation, and cell death. J. Pharmacol. Exp. Ther. 328, 708-714 (2009).
39. Bedard, K., Krause, K. H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol. Rev. 87, 245-313 (2007).
40. Kim, H. J. et al. Roles of NADPH oxidases in cisplatin-induced reactive oxygen species generation and ototoxicity. J. Neurosci. 30, 3933-3946 (2010).
41. Sahu, B. D., Kuncha, M., Sindhura, G. J., Sistla, R. Hesperidin attenuates cisplatin-induced acute renal injury by decreasing oxidative stress, inflammation and DNA damage. Phytomedicine 20, 453-460 (2013).
42. Ademiluyi, A. O., Oboh, G., Agbebi, O. J., Oyeleye, S. I. Dietary inclusion of sorghum (Sorghum bicolour) straw dye protects against cisplatin-induced nephrotoxicity and oxidative stress in rats. Pharm. Biol. 52, 829-834 (2014).
43. Sahin, K. et al. Comparative In Vivo Evaluations of Curcumin and Its Analog Difluorinated Curcumin Against Cisplatin-Induced Nephrotoxicity. Biol. Trace Elem. Res. 157, 156-163 (2014).
44. Ueki, M., Ueno, M., Morishita, J., Maekawa, N. Curcumin ameliorates cisplatin-induced nephrotoxicity by inhibiting renal inflammation in mice. J. Biosci. Bioeng. 115, 547-551 (2013).
45. Shaw, J., Media, J., Chen, B., Valeriote, F. The small-molecule TNF-inhibitor, UTL-5 g, delays deaths and increases survival rates for mice treated with high doses of cisplatin. Cancer Chemother. Pharmacol. 72, 703-707 (2013).
46. Litterst, C. L., Schweitzer, V. G. Covalent binding of platinum to renal protein from sensitive and resistant guinea pigs treated with cisplatin: possible role in nephrotoxicity. Res. Commun. Chem. Pathol. Pharmacol. 61, 35-48 (1988).
47. Mahran, Y. F., Khalifa, A. E., El-Demerdash, E. A comparative study of protective mechanisms of glycine and L-arginine against cisplatin-induced nephrotoxicity in rat renal cortical slices. Drug Discov. Ther. 5, 32-40 (2011).
48. Lee, R. H. et al. Cisplatin-induced apoptosis by translocation of endogenous Bax in mouse collecting duct cells. Biochem. Pharmacol. 62, 1013-1023 (2001).
49. Theodoratos, A. et al. Prevention of Cisplatin-induced nephrotoxicity by dichloroacetate. Pathology 46 Suppl 1, S110-S111 (2014).
50. Gao, S. et al. Cyanidin reverses cisplatin-induced apoptosis in HK-2 proximal tubular cells through inhibition of ROS-mediated DNA damage and modulation of the ERK and AKT pathways. Cancer Lett. 333, 36-46 (2013).
51. Pan, H. et al. Protective Effect of Metalloporphyrins against Cisplatin-Induced Kidney Injury in Mice. PLoS One 14, 9(1), e86057 (2014).
52. Ledeganck, K. J., Boulet, G. A., Bogers, J. J., Verpooten, G. A., De Winter, B. Y. The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. PLoS One 8, e57016 (2013).
53. Yasuda, H. et al. Insulin-like growth factor-I increases p21 expression and attenuates cisplatin-induced acute renal injury in rats. Clin. Exp. Nephrol. 8, 27-35 (2004).
54. Helmy, M. W., Helmy, M. M., Abd Allah, D. M., Abo Zaid, A. M., Mohy El-Din, M. M. Role of nitrergic and endothelin pathways modulations in cisplatin-induced nephrotoxicity in male rats. J. Physiol. Pharmacol. 65, 393-399 (2014).
55. Brain, S. D., Williams, T. J., Tippins, J. R., Morris, H. R., MacIntyre, I. Calcitonin gene-related peptide is a potent vasodilator. Nature 313, 54-56 (1985).
56. Edwards, R. M., Trizna, W. Calcitonin gene-related peptide: effects on renal arteriolar tone and tubular cAMP level. Am. J. Physiol. 258, F121-F125 (1990).
57. Zaidi, M., Datta, H., Bevis, P. J. Kidney: a target organ for calcitonin gene-related peptide. Exp. Physiol. 75, 27-32 (1990).
58. Li, J., Carnevale, K. A., Dipette, D. J., Supowit, S. C. Renal protective effects of-calcitonin gene-related peptide in deoxycorticosterone-salt hypertension. Am. J. Physiol. Renal Physiol. 304, F1000-F1008 (2013).
59. Okajima, K., Harada, N., Uchiba, M., Isobe, H. Activation of capsaicin-sensitive sensory neurons by carvedilol, a nonselective beta-blocker, in spontaneous hypertensive rats. J. Pharmacol. Exp. Ther. 309, 684-691 (2004).
60. De Santi, M., Galluzzi, L., Duranti, A., Magnani, M., Brandi, G. The Indole-3-carbinol cyclic tetrameric derivative CTet synergizes with cisplatin and doxorubicin in triple-negative breast cancer cell lines. Anticancer Res. 33, 1867-1872 (2013).